Encapsulating Peritoneal Sclerosis: Clinical Significance and Implications

By  

Nephron Clin Pract, Vol. 111, Iss. 2, 2009-01 ,pp. : c149-c154

Karger

Access to resources Recommend Favorite

Late presentation of encapsulating peritoneal sclerosis following renal transplantation and the potential under‐reporting of the incidence and prevalence of encapsulating peritoneal sclerosis

By  

NEPHROLOGY, Vol. 20, Iss. 7, 2015-07 ,pp. : 499-501

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pentoxifylline inhibits the fibrogenic activity of pleural effusions and transforming growth factor-beta

By Entzian P.   Schlaak M.   Seitzer U.   Acil Y.   Ernst M.   Zabel P.  

Mediators of Inflammation, Vol. 6, Iss. 2, 1997-04 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

The Control of Fibrosis in Systemic Sclerosis: A Strategy Involving Extracellular Matrix, Cytokines, and Growth Factors

By  

THE JOURNAL OF DERMATOLOGY, Vol. 21, Iss. 1, 1994-01 ,pp. : 1-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential Action of IL-4 and IL-13 as Fibrogenic Factors on Lung Fibroblasts in vitro

By  

International Archives of Allergy and Immunology, Vol. 132, Iss. 2, 2003-11 ,pp. : 168-176

Karger

Access to resources Recommend Favorite